Ordr Publishes Connected Device Security Maturity Model to Guide Healthcare Organizations on the Path to Zero Trust

Ordr, the leader in connected device security, today published a maturity model aimed at helping healthcare organizations benchmark their connected device security efforts and develop a strategy to improve the efficiency and strength of their security programs.

Entitled “A Practical Guide: Implementing Connected Device Security for Healthcare Organizations,” the document serves as a framework for healthcare security teams, helping them understand where their organization is on the connected device security maturity curve, and where to focus efforts to make improvements. The guide organizes the stages of maturity into five steps, including detailed descriptions, requirements, and the potential business value realized at each stage. Recommended actions, technical considerations, and helpful insights are included as well, to help teams learn how to improve their security posture, become more resilient, and advance their security efforts as they move toward Zero Trust.

Connected devices play an essential role within a healthcare organization – gathering data, providing diagnostics and therapeutic functions, and automating activities. But those same connected devices also expand the attack surface and create risk for healthcare providers. In fact, the healthcare sector faced the most ransomware attacks of any industry last year, according to the FBI’s 2021 Internet Crime Report, resulting in losses of $6.9 billion.

“A majority of healthcare organizations today rely on Internet of Things (IoT), Internet of Medical Things (IoMT), and Operational Technology (OT) devices to provide critical patient care, improve efficiencies, and manage the facility. The truth is, connected devices are everywhere in healthcare, which can make protecting them a daunting task,” said Pandian Gnanaprakasam, Chief Product Officer and co-founder of Ordr. “At Ordr, we’ve gained deep expertise working with customers of all sizes and at all stages of maturity. We understand the complexities that security teams in healthcare struggle with everyday – and we’re proud to share our insights with the community, to be used as a guide on the journey to Zero Trust.”

The five steps of the maturity model include:

Asset Visibility: This stage includes creating a complete, accurate and up-to-date asset inventory by automating discovery and classification for all known, unknown, and new devices, in addition to identifying risks.

Vulnerability and Risk Management: This stage encompasses creating a risk-based view of connected devices by combining device vulnerability insights, establishing device behavior baselines, and reviewing external threat intelligence inputs to gain a comprehensive view of the attack surface, guiding security efforts.

Reactive Security: This stage uses connected device insights and the risk-based view from the previous stages, combined with business context, to help teams understand device risk in their unique environment, prioritizing risk mitigation and incident response efforts.

Proactive Security: In this stage, teams automate policies and workflows to ensure rapid threat detection and response. Teams also develop and implement proactive measures such as Zero Trust segmentation to reduce the attack surface ahead of threats, enabling teams to focus on more complex threats.

Optimized Security: At this stage, teams continue to build on the foundation they have created to expand and optimize their security methods with automation and proactive Zero Trust security policies, aligning and scaling with organizational demands.

“While all industries are at risk of cyberattack, the potential outcomes of attacks on healthcare organizations could be catastrophic, with real consequences for patients,” added Brad LaPorte, author of the guide and former Gartner cybersecurity analyst. “Organizations cannot expect to reach the Optimized Security stage instantly. Each stage establishes critical capabilities, builds upon previous stages, and creates value on the journey to Zero Trust. No matter where you are on this journey and what your ultimate goal is, this guide provides essential insights to understanding your security posture – and what is needed to improve.”

To learn more about Ordr’s connected device security maturity model for healthcare organizations, please sign up for the January 19th Ordr of Business webinar: Healthcare’s Guide to Connected Device Security Maturity Model – The Road to Zero Trust.

SourceOrdr
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version